PAPSS1 and neoplasm: Ovarian tumor xenografts with PAPSS1-targeting shRNAs was determined to be effective at slowing the rate of tumor growth in animals, and PAPSS1 suppression/cisplatin combination was superior to cisplatin in the inhibition of tumor growth.